Arrowhead Research Corporation (ARWR) Subsidiary Calando Pharmaceuticals, Inc. Expands Board of Directors
11/4/2009 9:15:05 AM
More...
|
Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation (ARWR)
6/23/2009 3:43:33 PM
More...
|
Calando Pharmaceuticals, Inc. Publishes New Results of siRNA Delivery Using Its RONDEL(TM) Technology in Sepsis
12/8/2008 9:29:41 AM
More...
|
Calando Pharmaceuticals, Inc. to Present at 19th Annual Oppenheimer Healthcare Conference on November 4, 2008
11/3/2008 10:32:02 AM
More...
|
Calando Pharmaceuticals, Inc. Announces Completion of IT-101 Phase 1 Clinical Study
10/23/2008 9:57:08 AM
More...
|
Arrowhead Research Corporation (ARWR) CEO Provides Update on Majority Owned Subsidiary Calando Pharmaceuticals, Inc.
10/21/2008 9:57:36 AM
More...
|
Calando Pharmaceuticals, Inc. Patent Issued For Active Ingredient Of Lead siRNA Drug Candidate, CALAA-01
10/7/2008 10:01:07 AM
More...
|
Calando Pharmaceuticals, Inc. Announces Next siRNA Therapeutic Candidate for Oncology
9/15/2008 9:14:34 AM
More...
|
Calando Pharmaceuticals, Inc. Phase II Clinical Study Opens to Patient Enrollment
9/11/2008 8:36:54 AM
More...
|
Alnylam Pharmaceuticals (ALNY) Grants New InterfeRx(TM) Intellectual Property License to Calando Pharmaceuticals, Inc. for Development and Commercialization of RNAi Therapeutics
7/21/2008 6:18:33 AM
More...
|
|